Skip to main content

Davy Global Fund Management Ltd

SEC CIK
0001620943
Latest filing
Jul 31, 2026

PMCB holding history

PharmaCyte Biotech, Inc. in every 13F filed by Davy Global Fund Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PMCB overviewAll 13F holders of PMCBFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2022
Holdings of PMCB by Davy Global Fund Management Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−40,800−100.0%Sold outHolders
Q4 202240,800$119.5K<0.1%+2,029+5.2%AddedHolders
Q3 202238,771$93.0K<0.1%+38,771NewHolders